| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
Farletuzumab manufacturers
- Farletuzumab
-
- $228.00
-
2026-05-21
- CAS:896723-44-7
- Purity: > 95%
- Supply Ability: 10g
|
| | Farletuzumab Basic information |
| Product Name: | Farletuzumab | | Synonyms: | Farletuzumab;Farletuzuma;Research Grade Farletuzumab(DHD10401);Farletuzumab (anti-FOLR1);MORAb-003;Research Grade Farletuzumab | | CAS: | 896723-44-7 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Farletuzumab Structure]() |
| | Farletuzumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Farletuzumab Usage And Synthesis |
| Uses | Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer[1]. | | References | [1] Ebel W, et, al. Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immun. 2007 Mar 9;7:6. PMID:17346028 |
| | Farletuzumab Preparation Products And Raw materials |
|